256P Difference of immunological status and response to immune checkpoint inhibitor between recurrent and de novo stage IV HER2-negative breast cancer in NEWBEAT trial (WJOG9917BTR)

Autor: Y. Ozaki, S. Kitano, M. Yamashita, D. Ikarashi, J. Tsurutani, T. Iwasa, M. Takahashi, T. Mukohara, N. Masuda, M. Futamura, H. Minami, K. Matsumoto, Y. Tanabe Hashimoto, H. Kawabata, K. Yoshimura, T. Takano
Rok vydání: 2022
Předmět:
Zdroj: Annals of Oncology. 33:S654
ISSN: 0923-7534
DOI: 10.1016/j.annonc.2022.07.295
Databáze: OpenAIRE